BCR-ABL1 H396R
|
CML
|
BCR-ABL1 H396R
|
CML
|
dasatinib Sensitive: B - Late Trials
|
dasatinib Sensitive: B - Late Trials
|
BCR-ABL1 H396R
|
CML
|
BCR-ABL1 H396R
|
CML
|
bosutinib Resistant: C3 – Early Trials
|
bosutinib Resistant: C3 – Early Trials
|
BCR-ABL1 H396R
|
CML
|
BCR-ABL1 H396R
|
CML
|
nilotinib Sensitive: D – Preclinical
|
nilotinib Sensitive: D – Preclinical
|
BCR-ABL1 H396R
|
CML
|
BCR-ABL1 H396R
|
CML
|
imatinib Sensitive: D – Preclinical
|
imatinib Sensitive: D – Preclinical
|